At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 120 enrolled
Drug / intervention
lansoprazole OD +1 moredrug
Likely dose
lansoprazole OD 30 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase IV Study of Comparison of the Efficacy for Stress Ulcer Prophylaxis Between the Patients Received Lansoprazole OD and Control Group Weaning From Mechanical Ventilator in Respiratory Care Center: a Randomized Control Trial
In Brief
A Phase 4 clinical trial evaluating lansoprazole OD and placebo for Respiratory Failure. Completed, enrolled 120 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether lansoprazole administered nasogastrically is effective for stress ulcer prophylaxis in respiratory intensive care unit.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRespiratory Failure
CountriesTaiwan
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 2008
Enrollment StartJun 2009
Primary CompletionFeb 2012
TodayJul 2026
First PostedJul 2, 2008
Enrollment StartJun 1, 2009
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 18 years ago
Interventions
lansoprazole ODdrug
arm 1: lansprazole 30 mg qd from NG route or orally for 14 days
placebodrug
takepron placebo